Evidence map›Paper›PMID 21492450›Full record

ArticleBMC neuroscience2011

MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma.

Emanuela Esposito, Irene Paterniti, Emanuela Mazzon, Tiziana Genovese, Maria Galuppo, Rosaria Meli, Placido Bramanti, Salvatore Cuzzocrea

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in BMC neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. An update on spinal cord injury research.Neuroscience bulletin · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Emanuela EspositoDepartment of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Italy.
Irene Paterniti
Emanuela Mazzon
Tiziana Genovese
Maria Galuppo
Rosaria Meli
Placido Bramanti
Salvatore Cuzzocrea
University of Messina · ITCentro Neurolesi Bonino Pulejo · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlutamergic excitotoxicity has been shown to play a deleterious role in the pathophysiology of spinal cord injury (SCI). The aim of this study was to investigate the neuroprotective effect of dizocilpine maleate, MK801 (2 mg/Kg, 30 min and 6 hours after injury) in a mice model of SCI. The spinal cord trauma was induced by the application of vascular clips to the dura via a four-level T5-T8 laminectomy.

resultsSpinal cord injury in mice resulted in severe trauma characterized by edema, neutrophil infiltration and apoptosis. In this study we clearly demonstrated that administration of MK801 attenuated all inflammatory parameters. In fact 24 hours after injury, the degree of spinal cord inflammation and tissue injury (evaluated as histological score), infiltration of neutrophils, NF-κB activation, iNOS, cytokines levels (TNF-α and IL-1β), neurotrophin expression were markedly reduced by MK801 treatment. Moreover, in a separate set of experiments, we have demonstrated that MK801 treatment significantly improved the recovery of locomotory function.

conclusionsBlockade of NMDA by MK801 lends support to the potential importance of NMDA antagonists as therapeutic agents in the treatment of acute spinal cord injury.

Indexed as

Disease Models, AnimalAnimalsCytokinesDizocilpine MaleateDose-Response Relationship, DrugHumansMaleMiceNerve Growth FactorsReceptors, GlutamateSpinal CordSpinal Cord CompressionTreatment OutcomeCytokinesDizocilpine MaleateNerve Growth FactorsReceptors, Glutamate

Identifiers

PMID21492450
PMCPMC3094200
OpenAlexW2048872961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.